Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
BMC Cancer|September 6, 2013
Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in SpainGuillermo Villa, Luis-Javier Hernández-PastorFarmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 17, 2013
[Efficiency of initiation with ambrisentan versus bosentan in the treatment of pulmonary arterial hypertension]Guillermo Villa, Raúl Morano, Antonio Román, et al.Journal of Market Access & Health Policy|January 12, 2018
Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-yearsBorislav Borissov, Michael Urbich, Boryana Georgieva, et al.Revista Peruana De Medicina Experimental Y Salud Publica|September 6, 2018
[Urinary Arsenic Concentrations In Adult Population Of Two Districts From The Tacna Region, Peru, 2017]Diego A Ale-Mauricio, Guillermo Villa, María Del Carmen GastañagaEuropean Journal of Preventive Cardiology|April 23, 2021
Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United KingdomMark D Danese, Peter Pemberton-Ross, David Catterick, et al.JAMA Cardiology|June 6, 2019
Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular DiseaseGregg C Fonarow, Ben van Hout, Guillermo Villa, et al.European Heart Journal. Quality of Care & Clinical Outcomes|October 19, 2017
Prediction of cardiovascular risk in patients with familial hypercholesterolaemiaGuillermo Villa, Bruce Wong, Lucie Kutikova, et al.BMC Health Services Research|August 18, 2012
Cost-effectiveness analysis of timely dialysis referral after renal transplant failure in SpainGuillermo Villa, Emilio Sánchez-Álvarez, Jesús Cuervo, et al.Advances in Therapy|July 27, 2021
Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort StudyEmil Hagström, Francesc Sorio Vilela, Maria K Svensson, et al.Pharmacoeconomics - Open|November 1, 2018
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled TrialsJoshua K Porter, Gian Luca Di Tanna, Richard B Lipton, et al.Pageof 5